Details for Patent: 11,975,001
✉ Email this page to a colleague
Which drugs does patent 11,975,001 protect, and when does it expire?
Patent 11,975,001 protects LYNPARZA and is included in one NDA.
This patent has fifty-two patent family members in forty-two countries.
Drugs Protected by US Patent 11,975,001
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | LYNPARZA | olaparib | TABLET;ORAL | 208558-001 | Aug 17, 2017 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Astrazeneca | LYNPARZA | olaparib | TABLET;ORAL | 208558-002 | Aug 17, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,975,001
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2346495 | ⤷ Sign Up | 300956 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2346495 | ⤷ Sign Up | 122018000124 | Germany | ⤷ Sign Up |
| European Patent Office | 2346495 | ⤷ Sign Up | CA 2018 00039 | Denmark | ⤷ Sign Up |
| European Patent Office | 2346495 | ⤷ Sign Up | PA2018014 | Lithuania | ⤷ Sign Up |
| European Patent Office | 2346495 | ⤷ Sign Up | LUC00091 | Luxembourg | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
